Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular and functional characterization of allergens: basic and practical aspects

O Scheiner1, H Breiteneder, C Dolocek

  • 1Universität Wien, Austria.

Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An uncommon case of POLE mutated uterine carcinosarcoma - complemented by a review of literature.

Gynecologic oncology reports·2024
Same author

Evaluation of 'implications for research' statements in systematic reviews of interventions in advanced cancer patients - a meta-research study.

BMC medical research methodology·2023
Same author

When and how do patients with cardiac amyloidosis die?

Clinical research in cardiology : official journal of the German Cardiac Society·2019
Same author

Distinct epitope structures of defensin-like proteins linked to proline-rich regions give rise to differences in their allergenic activity.

Allergy·2017
Same author

Amb a 1 isoforms: Unequal siblings with distinct immunological features.

Allergy·2017
Same author

Influence of the Ag concentration on the medium-range order in a CuZrAlAg bulk metallic glass.

Scientific reports·2017
Same journal

Quality and clinical efficacy of allergen mixtures.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

A bright future for sublingual immunotherapy--contra.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

A bright future for sublingual immunotherapy?--pro.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

Prospects for CpG based immunotherapy in asthma and allergy.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
Same journal

Understanding the immunological basis of asthma; immunotherapy and regulatory T cells.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M·2007
See all related articles

Recombinant DNA technology enables the production of standardized, highly purified allergens for accurate allergy diagnosis and effective immunotherapy. This approach aids in understanding allergen function and developing novel treatment strategies for IgE-mediated allergic diseases.

Area of Science:

  • Allergen research
  • Immunotherapy
  • Molecular biology

Background:

  • Standardized and purified allergens are crucial for precise diagnosis and immunotherapy of Type I (IgE-mediated) allergic diseases.
  • Current methods for allergen preparation face challenges in standardization, purification, and quantity.

Purpose of the Study:

  • To explore the application of recombinant DNA techniques for producing well-defined allergen preparations.
  • To investigate the characterization, reproducibility, and immunological properties of recombinant allergens.
  • To understand the biological function and therapeutic potential of allergens.

Main Methods:

  • Recombinant DNA technology was employed to clone and express allergens.
  • Purified recombinant non-fusion Betv1 was compared to natural Betv1 for immunological properties.

Related Experiment Videos

  • Deduced primary structures of cloned allergens were analyzed for sequence similarities.
  • Interaction of synthesized allergen peptides with T and B cells was investigated.

    • Main Results:

    • Recombinant non-fusion Betv1 demonstrated identical immunological properties to natural Betv1.
    • Recombinant DNA techniques facilitate characterization and reproducibility of allergen preparations.
    • Analysis of allergen sequences provides insights into their biological and biochemical functions.
    • Investigating peptide interactions with immune cells offers information on IgE regulation.

    Conclusions:

    • Recombinant DNA technology is a powerful tool for producing standardized, highly purified allergens.
    • This technology enhances allergen characterization, reproducibility, and understanding of function.
    • Findings pave the way for novel immunotherapy strategies by elucidating IgE regulation mechanisms.